27-06-2022 Relapsed Refractory Hodgkin Lymphoma management
In this Deep Dive Session, Prof. Pier Luigi Zinzani, from the University of Bologna, discusses the use of PD-1 inhibitors in the treatment of relapsed or refractory Hodgkin’s lymphoma. He […]
27-06-2022 Relapsed Refractory Hodgkin Lymphoma management Read More »